Last reviewed · How we verify
Intravenous Immunoglobulins, Human
Intravenous Immunoglobulins, Human is a Small molecule drug developed by Meyer Children's Hospital IRCCS. It is currently FDA-approved. Also known as: IVIG.
At a glance
| Generic name | Intravenous Immunoglobulins, Human |
|---|---|
| Also known as | IVIG |
| Sponsor | Meyer Children's Hospital IRCCS |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Clinical Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer (PHASE3)
- Monitoring of Donor-specific Antibodies After Treatment With Immunoglobulins, Plasmapheresis and Rituximab in Lung Transplantation
- Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors (PHASE1)
- A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy (PHASE2)
- Rituximab for Anti-cytokine Autoantibody-Associated Diseases (PHASE1)
- Cemiplimab Plus Fianlimab for the Treatment of Locally Advanced Head and Neck Basal Cell Carcinoma Before Surgery (PHASE2)
- A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV (PHASE1)
- Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Intravenous Immunoglobulins, Human CI brief — competitive landscape report
- Intravenous Immunoglobulins, Human updates RSS · CI watch RSS
- Meyer Children's Hospital IRCCS portfolio CI
Frequently asked questions about Intravenous Immunoglobulins, Human
What is Intravenous Immunoglobulins, Human?
Intravenous Immunoglobulins, Human is a Small molecule drug developed by Meyer Children's Hospital IRCCS.
Who makes Intravenous Immunoglobulins, Human?
Intravenous Immunoglobulins, Human is developed and marketed by Meyer Children's Hospital IRCCS (see full Meyer Children's Hospital IRCCS pipeline at /company/meyer-children-s-hospital-irccs).
Is Intravenous Immunoglobulins, Human also known as anything else?
Intravenous Immunoglobulins, Human is also known as IVIG.
What development phase is Intravenous Immunoglobulins, Human in?
Intravenous Immunoglobulins, Human is FDA-approved (marketed).
Related
- Manufacturer: Meyer Children's Hospital IRCCS — full pipeline
- Also known as: IVIG